1. Home
  2. EPOW vs CTSO Comparison

EPOW vs CTSO Comparison

Compare EPOW & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EPOW

Sunrise New Energy Co. Ltd

N/A

Current Price

$4.82

Market Cap

24.2M

ML Signal

N/A

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

N/A

Current Price

$4.60

Market Cap

23.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EPOW
CTSO
Founded
2014
1997
Country
China
United States
Employees
N/A
N/A
Industry
Business Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.2M
23.9M
IPO Year
2019
2008

Fundamental Metrics

Financial Performance
Metric
EPOW
CTSO
Price
$4.82
$4.60
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $12.25
AVG Volume (30 Days)
28.9K
★ 60.5K
Earning Date
05-15-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 65.79
EPS
★ N/A
N/A
Revenue
N/A
★ $22,503,908.00
Revenue This Year
N/A
$4.91
Revenue Next Year
N/A
$13.58
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 48.53
52 Week Low
$0.26
$0.30
52 Week High
$7.66
$7.44

Technical Indicators

Market Signals
Indicator
EPOW
CTSO
Relative Strength Index (RSI) 61.71 52.02
Support Level $0.55 $2.88
Resistance Level $7.66 $7.20
Average True Range (ATR) 0.50 0.80
MACD 0.12 -0.02
Stochastic Oscillator 74.30 43.08

Price Performance

Historical Comparison
EPOW
CTSO

About EPOW Sunrise New Energy Co. Ltd

E Power Inc, through its subsidiaries, is engaged in the manufacturing and sale of graphite anode material for lithium-ion batteries. It operates a plant in Guizhou Province, China, powered by electricity from renewable sources, which contributes to the plant's low production costs and reduced environmental impact in the production of graphite anode materials. Additionally, the Group also operates a knowledge-sharing platform business. Its reportable operating segments are: Graphite anode business, which generates the maximum revenue, and Knowledge sharing and enterprise business. Substantially all of the Group's revenue is derived in the People's Republic of China (the PRC).

About CTSO Cytosorbents Corporation

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

Share on Social Networks: